cdn mobile

7,200 doses of Sinovac vaccines arrive in Region 7

By: Morexette Marie Erram - CDN Digital | March 30,2021 - 11:19 AM

Sinovac vaccines

12 boxes of CoronaVac containing a total of 7,200 doses arrived at the Mactan Cebu International Airport (MCIA) at 7:40 a.m. | Photo courtesy of Radyo Pilipinas – Cebu

CEBU CITY, Philippines – Central Visayas on Tuesday, March 30, 2021, received another shipment of COVID-19 vaccines.

Twelve boxes of CoronaVac containing a total of 7,200 doses arrived at the Mactan Cebu International Airport (MCIA) at 7:40 a.m.

This batch of CoronaVac, the COVID-19 vaccine brand manufactured by China’s Sinovac Biotech, is Central Visayas’ share of the 1 million doses the Philippine government procured and delivered on Monday, March 29. 

These were immediately transported to the cold-storage facility within the compound of the Department of Health in Central Visayas (DOH-7).

This is the fifth shipment of COVID-19 vaccines sent to Central Visayas.

DOH-7 spokesperson Dr. Mary Jean Loreche, in earlier interviews, said they are expecting a total of additional 21,600 doses of  CoronaVac vaccine, including the 7,200 that arrived on Tuesday, to augment Central Visayas’ supply. 

/bmjo

Read: Region 7 to receive more Sinovac doses

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: CoronaVac, Department of Health in Central Visayas, DOH-7, Sinovac BioTech, Sinovac vaccines
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.